Zogenix (ZGNX) Stock Research, Analysis & News
Quick Analysis on Zogenix (ZGNX) Stock as of June 19, 2013
 | Previous Closing Price $1.50 is below its 50 day moving average $1.76 |
| Previous Closing Price $1.50 is below its 200 day moving average $1.87 |
 | The Stock pays no dividend |
 | The closing price $1.50 is more than 144.67% away from its one year target price of $3.67 |
 | Current Short Ratio 9.40 is great than 1 |
| Earning per Share $-0.65 is negative. Zogenix is lossing money. |
| EBITDA $-53.2M is negative |
| It is a very small cap stock with market cap of $151.2M |
(See more information about Zogenix (ZGNX) Stock below)
Zogenix (ZGNX) Stock Profile Summary
Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. The companys principal commercial product includes SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System for the acute treatment of migraine and cluster headache. It also offers ZX002, a novel, oral, single-entity controlled-release formulation of hydrocodone that is in Phase 3 clinical trials for the treatment of moderate to severe chronic pain in patients requiring around-the-clock opioid therapy. In December 2010, the company received approval from the Danish Medicines Agency of Denmark for the Marketing Authorization Application for SUMAVEL DosePro Needle-Free Delivery System. Zogenix, Inc. was founded in 2006 and is based in San Diego, California.
Zogenix (ZGNX) Stock Key Statistics Research and Analysis as of June 19, 2013
| Stock Exchange | NGM |
| Market Capitalization | $151.2M
|
| Trade Volume (Average Trading Volume) | 0 (1,197,100) |
| Price/Sales | 4.59 |
| Earning/Share | $-0.65 |
| Current Year EPS Estimate | $-0.59 |
| Next Year EPS Estimate | $-0.33 |
| Previous Closing Price | $1.50 |
| 50 Day Price Moving Average | $1.76 |
| 200 Day Price Moving Average | $1.87 |
| 1 yr Target Price | $3.67 |
| Short Ratio | 9.40 |
| EBITDA | $-53.2M |
Zogenix (ZGNX) Stock Competitor Research and Analysis
Latest Market News on Zogenix (ZGNX)
Click here to find the latest news on Zogenix (ZGNX)
Looking for Market Opportunties?
Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center
See other companies in the same industry
AstraZeneca PLC (AZN) GlaxoSmithKline plc (GSK) Pfizer Inc. (PFE) Amgen Inc. (AMGN) Biogen Idec Inc. (BIIB) Genzyme Corp. (GENZ) Gilead Sciences Inc. (GILD) Life Technologies Corporation (LIFE) Teva Pharmaceutical Industries Limited (TEVA) Watson Pharmaceuticals Inc. (WPI) King Pharmaceuticals Inc. (KG) Mylan, Inc. (MYL) Johnson & Johnson (JNJ) Sanofi-Aventis (SNY) Novartis AG (NVS)
Research on Zogenix (ZGNX)
